Gary L. Crump, MD, FACR

SAN DIEGO — Approximately 75% of patients in rheumatoid arthritis remission who taper TNF inhibitors to withdrawal experience a flare within 3 years, according to data presented at ACR Convergence 2023.

Approximately 83% of patients with fibromyalgia demonstrate visually straight cervical spines, according to data published in the Journal of Clinical Rheumatology.

Platelet-rich plasma injections failed to improve knee osteoarthritis symptoms or joint structure at 12 months, compared with a saline placebo, in patients with symptomatic, mild-to-moderate radiographic disease, according to data.

A daily 30 mg dose of upadacitinib — but not the 15 mg dose — is superior to adalimumab at improving the signs and symptoms of psoriatic arthritis among patients with inadequate response to non-biologic disease-modifying antirheumatic drugs.

Although cannabidiol — better known as CBD — may help patients with arthritis alleviate their pain, insomnia and anxiety, there have been no rigorous clinical studies to confirm these effects, and the product should never be used to replace DMARDs that prevent permanent joint damage, according to guidance from the Arthritis Foundation.